Roquette expands its business horizon in pharmaceutical excipients market

Date: 2017-06-23   Author: Saipriya Iyer  Category: #news

Roquette expands its business horizon in pharmaceutical excipients market

Roquette, a global supplier of plant based innovative pharmaceutical ingredients has recently announced its strategic acquisition of the renowned Brazilian tablet maker, Itacel, which is essentially a subdivision of the well-known excipients manufacturer, Blanver. This strategic investment will extend Roquette’s penetration in the regional landscape of Latin America, since Itacel, in the present scenario is a front runner in Latin America’s food excipients and pharmaceutical markets. With this acquisition, Roquette will have the opportunity to establish a strong customer base across this belt, state industry analysts.

Founded in 1933, Roquette, the France rooted firm, presently supplies a range of plant-based natural food supplements and reportedly has a yearly turnover of more than USD 2 billion. Itacel, on the other hand, headquartered in Brazil, has already gained an international popularity in the pharmaceutical industry with its novel product offering that is used for drug formulations. Indeed, the acquisition is not only slated to mark the entry of a new competitor in the pharmaceutical excipients market, but is also forecast to allow Roquette enhance its contribution toward the food, health, and nutrition sectors. As per reliable reports, Itacel’s parent company Blanver is now interested in establishing two other business forums - active pharmaceutical ingredients and medicines, which seems to be the sole cause of divesting its excipients business.

Subject to the customary conditions in terms of commercial support, industrial assets, technical know-how, and product portfolio enrichment, the union of these two well-established firms is expected to simultaneously profit one another.  As stated by a higher official, through this strategic alliance, Roquette will introduce its expertise in the business that would further enrich Itacel’s long held cellulose based infrastructure and assets. The newly joint business model is expected to establish a better customer reach in the excipients market, addressing the future needs through more innovative solutions.

This collaborative approach also marks a milestone in the global pharmaceutical industry. Blanver’s domination in the excipients market across Latin America and Brazil will add a significant benefit to Roquette’s innovative product manufacturing capabilities, infrastructural asset, and commercial network. In a way, Roquette is on its way to expand its business in other emerging markets as well. Experts state that a robust growth forecast in global pharmaceutical excipients market in the coming few years will further push the business development. In addition, this strategic investment is expected to address the needs of the rapidly emerging nutraceutical and pharmaceutical sectors.



About Author


Saipriya Iyer linkdin-boxtwitter

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

Post Recommendents

Antenatal Screening Market Share, By Product Analysis, Application, End-Use, Regional Outlook, Competitive Strategies & Forecast up to 2028

Author: Ashwin Naphade

Global Antenatal Screening Market, 2022-2028 Research Report provides crucial statistics on the market status of the Global Antenatal Screening manufacturers and is a respected source of guidance and direction for companies and individuals interes...


Pediatric Vitrectomy Market Size | Global Industry Analysis, Segments, Top Key Players, Drivers and Trends to 2028

Author: Ashwin Naphade

Global Pediatric Vitrectomy market report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

The Pediatric Vitrectomy market repor...


Legionnaire Disease Testing Market Comprehensive Analysis, Share, Growth Forecast from 2022 to 2028c

Author: Ashwin Naphade

This report studies the Global Legionnaire Disease Testing market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, ...